Patents by Inventor Ekkehard Lang

Ekkehard Lang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A CLEAN ROOM SYSTEM AS WELL AS A COMPUTER IMPLEMENTED METHOD FOR CONTROLLING SUCH CLEAN ROOM SYSTEM
    Publication number: 20230408116
    Abstract: The invention relates to the field of clean room facilities for manufacturing of a pharmaceutical product or item according to a sequence of manufacturing steps under extreme low levels of particulates.
    Type: Application
    Filed: October 13, 2021
    Publication date: December 21, 2023
    Inventors: Johannes Petrus Jozef Maria DE MUNTER, Ekkehard LANG
  • Method for reducing the inflammatory activity of a stem cell transplant and use thereof
    Patent number: 10406181
    Abstract: The disclosure is in the field of cell therapy, more in particular, stem cell transplantation therapy. The disclosure provides methods and compositions for improving the efficacy of stem cell transplantation therapy by reducing the inflammatory activity of a stem cell transplant. More in particular, the disclosure provides a method for preparing a stem cell transplant with reduced inflammatory activity comprising a step of suspending a composition comprising stem cells in a fibrinogen-depleted plasma and/or in a fibrinogen and C-reactive protein-depleted plasma.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: September 10, 2019
    Assignee: Neuroplast Beheer B.V.
    Inventors: Johannes Petrus Jozef Maria De Munter, Ekkehard Lang, Erik Charles Marie Joseph Wolters, Petrus Theodorus De Haan
  • METHOD FOR REDUCING THE INFLAMMATORY ACTIVITY OF A STEM CELL TRANSPLANT AND USE THEREOF
    Publication number: 20180042967
    Abstract: The disclosure is in the field of cell therapy, more in particular, stem cell transplantation therapy. The disclosure provides methods and compositions for improving the efficacy of stem cell transplantation therapy by reducing the inflammatory activity of a stem cell transplant. More in particular, the disclosure provides a method for preparing a stem cell transplant with reduced inflammatory activity comprising a step of suspending a composition comprising stem cells in a fibrinogen-depleted plasma and/or in a fibrinogen and C-reactive protein-depleted plasma.
    Type: Application
    Filed: October 24, 2017
    Publication date: February 15, 2018
    Applicant: Neuroplast Beheer B.V.
    Inventors: Johannes Petrus Jozef Maria De Munter, Ekkehard Lang, Erik Charles Marie Joseph Wolters, Petrus Theodorus De Haan
  • Method for reducing the inflammatory activity of a stem cell transplant and use thereof
    Patent number: 9839653
    Abstract: The disclosure is in the field of cell therapy, more in particular, stem cell transplantation therapy. The disclosure provides methods and compositions for improving the efficacy of stem cell transplantation therapy by reducing the inflammatory activity of a stem cell transplant. More in particular, the disclosure provides a method for preparing a stem cell transplant with reduced inflammatory activity comprising a step of suspending a composition comprising stem cells in a fibrinogen-depleted plasma and/or in a fibrinogen and C-reactive protein-depleted plasma.
    Type: Grant
    Filed: October 24, 2014
    Date of Patent: December 12, 2017
    Assignee: NEUROPLAST BEHEER B.V.
    Inventors: Johannes Petrus Jozef Maria De Munter, Ekkehard Lang, Erik Charles Marie Joseph Wolters, Petrus Theodorus De Haan
  • METHOD FOR REDUCING THE INFLAMMATORY ACTIVITY OF A STEM CELL TRANSPLANT AND USE THEREOF
    Publication number: 20160228468
    Abstract: The disclosure is in the field of cell therapy, more in particular, stem cell transplantation therapy. The disclosure provides methods and compositions for improving the efficacy of stem cell transplantation therapy by reducing the inflammatory activity of a stem cell transplant. More in particular, the disclosure provides a method for preparing a stem cell transplant with reduced inflammatory activity comprising a step of suspending a composition comprising stem cells in a fibrinogen-depleted plasma and/or in a fibrinogen and C-reactive protein-depleted plasma.
    Type: Application
    Filed: October 24, 2014
    Publication date: August 11, 2016
    Applicants: Neuroplast Beheer B.V., Neuroplast Beheer B.V.
    Inventors: Johannes Petrus Jozef Maria De Munter, Ekkehard Lang, Erik Charles Marie Joseph Wolters, Petrus Theodorus De Haan